This content is machine translated Measures after a stroke Effects of a Ginkgo biloba extract on cognitive functions. Given the high incidence of stroke events and subsequent cognitive impairment, there is a great need for new therapeutic options that can be used in early post-stroke phases. A randomized…
View Post 4 min This content is machine translated Systemic lupus erythematosus The future belongs to precision medicine The multiple disease manifestations of systemic lupus erythematosus (SLE) are essentially a consequence of autoantibodies, immune complexes, and cytokines. New therapies specifically intervene in the immunopathogenesis of the complex autoimmune…
View Post 7 min This content is machine translated CLEAR Outcomes Study New results on bempedoic acid Statin-intolerant patients represent a difficult patient group to treat in lipid management. Now, with the CLEAR Outcomes study, it has been shown that a therapeutic option with a beneficial effect…
View Post 6 min This content is machine translated Systemic lupus erythematosus What can belimumab and anifrolumab do? The monoclonal antibodies belimumab and anifrolumab are both approved for the treatment of systemic lupus erythematosus (SLE). Their response is considered to be highly effective. The point at which they…
View Post 5 min This content is machine translated "Atopic Dermatitis Patient Satisfaction and Unmet Need Survey." Patient satisfaction and care situation in atopic dermatitis. A research team collected data in ten countries to evaluate the benefits of current and previous treatment strategies for atopic dermatitis. The results should contribute to an improvement in “disease…
View Post 4 min This content is machine translated Gastrointestinal tumors Latest scientific findings from stomach to colon Themed “Applying Innovation, Transforming Care, Advancing Equity,” ASCO-GI celebrated its 20th anniversary this year. The focus this year was primarily on current findings relating to gastric carcinoma. However, further studies…
View Post 5 min This content is machine translated Heart failure in type 2 diabetes Success story of SGLT-2 inhibitors – impressive evidence base. The SGLT(“sodium glucose-linked transporter”)-2 inhibitors have demonstrated cardioprotective effects in addition to antidiabetic effects. The current evidence supports the benefit of several agents of SGLT-2-i in the treatment of heart…
This content is machine translated Rheumatoid arthritis in elderly patients Evidence-based therapy selection under the aspect of benefits and risks Current evidence suggests that the benefits of low-dose steroid therapy are greater than the harms in elderly patients with rheumatoid arthritis (RA). This is evident from the GLORIA study, in…
View Post 18 min This content is machine translated Cardiovascular diseases & sleep apnea News from the ominous duo Sleep-disordered breathing is now a recognized cardiac risk factor. It can trigger not only circulatory diseases such as hypertension and heart failure, but also atrial fibrillation. As a result, it…
View Post 3 min This content is machine translated GLP-1-RA and dual GLP-1/GIP agonists. Tackling obesity – not only diabetics benefit from the effects While glucagon-like peptide (GLP)-1 receptor agonists have been successfully used in the treatment of diabetes for some time, there are now agents that activate not only the GLP-1 receptor but…
View Post 5 min This content is machine translated Non-alcoholic fatty liver disease (NAFLD) What does the current guideline say? Non-alcoholic fatty liver disease is the most common liver disease worldwide. The German S2k guideline, updated in 2022, recommends screening patients at risk. The proposed screening algorithm includes fibrosis assessment…
